Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and the Merit-based Incentive Payment System.
Barbieri JS, Miller JJ, Nguyen HP, Forman HP, Bolognia JL, VanBeek MJ; Group for Research of Policy Dynamics in Dermatology. Barbieri JS, et al. J Am Acad Dermatol. 2017 Jun;76(6):1206-1212. doi: 10.1016/j.jaad.2017.01.032. Epub 2017 Mar 30. J Am Acad Dermatol. 2017. PMID: 28365038
Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and Children's Health Insurance Program Reauthorization Act and Alternative Payment Models in dermatology.
Barbieri JS, Miller JJ, Nguyen HP, Forman HP, Bolognia JL, VanBeek MJ; Group for Research of Policy Dynamics in Dermatology. Barbieri JS, et al. J Am Acad Dermatol. 2017 Jun;76(6):1213-1217. doi: 10.1016/j.jaad.2017.01.031. Epub 2017 Mar 30. J Am Acad Dermatol. 2017. PMID: 28365040
Commentary: Future considerations for clinical dermatology in the setting of 21st century American policy reform: The Medicare Access and CHIP Reauthorization Act of 2015.
Barbieri JS, Miller JJ, Nguyen HP, Forman HP, Bolognia JL, VanBeek MJ; Group for Research of Policy Dynamics in Dermatology. Barbieri JS, et al. J Am Acad Dermatol. 2017 Jun;76(6):1203-1205. doi: 10.1016/j.jaad.2017.01.033. Epub 2017 Mar 30. J Am Acad Dermatol. 2017. PMID: 28365041 No abstract available.
Lack of a US Food and Drug Administration indication should not limit access to appropriate treatment.
Albrecht J, Adamson AS, Barbieri JS, Bennett DD, Kiracofe EA, Kourosh AS, Leslie KS, Merola JF, Nguyen J, Siegfried E, Strickland N, Olbricht S, Asgari MM; American Academy of Dermatology Association Task Force on Drug Pricing and Transparency. Albrecht J, et al. Among authors: barbieri js. J Am Acad Dermatol. 2019 Feb;80(2):577-578. doi: 10.1016/j.jaad.2018.09.016. Epub 2018 Sep 20. J Am Acad Dermatol. 2019. PMID: 30244066 No abstract available.
250 results